Home Preserving sight: Managing and preventing diabetic retinopathy
Article Open Access

Preserving sight: Managing and preventing diabetic retinopathy

  • Mohd Altaf Dar , Mudasir Maqbool EMAIL logo , Irfat Ara and Zulfkar Qadrie
Published/Copyright: December 31, 2023
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Open Health
From the journal Open Health Volume 4 Issue 1

Abstract

Preserving eyesight in the presence of diabetic retinopathy, a subtle complication of diabetes, requires a proactive and comprehensive approach. This condition, characterized by the gradual deterioration of the blood vessels in the retina, can quietly advance and pose a significant threat to vision. Effectively managing this issue involves careful control of blood glucose levels through medications, dietary choices, and physical activity. By preventing prolonged high blood sugar levels, the main culprit behind retinal damage, individuals can slow down the progression of diabetic retinopathy and minimize its impact on vision. Medical interventions, such as laser therapies and anti-vascular endothelial growth factor injections, offer targeted measures to address abnormal blood vessel growth and leakage. Regular eye assessments are crucial, providing early detection opportunities even in the absence of obvious symptoms and allowing for timely intervention before irreversible damage occurs. Prevention is equally important, emphasizing proactive measures to avoid diabetic retinopathy. Monitoring blood pressure and lipid levels, along with adopting a health-conscious lifestyle, strengthens cardiovascular health, indirectly protecting the fragile retinal blood vessels. By following diabetes management protocols, maintaining a balanced diet, engaging in regular physical activity, and avoiding tobacco use, individuals can significantly reduce their vulnerability to diabetic retinopathy. Combined with efforts to increase community awareness and educate about the importance of regular eye check-ups, this comprehensive approach empowers individuals to actively manage their eye health, ultimately preserving the precious gift of sight.

Keywords: diabetic retinopathy; vision loss; blood sugar; education

1 Introduction

The amazing ability to see is a truly exceptional gift, allowing us to understand and connect with the world in meaningful ways. The complex interplay of light, color, and shape that our eyes transform into visual images profoundly influences how we perceive our surroundings and our place in them [1]. Yet, for many people dealing with diabetes, this incredible gift of sight is constantly under threat from a powerful foe: diabetic retinopathy. This slow and potentially vision-threatening complication serves as a clear reminder of the complex connection between metabolic health and the proper functioning of our eyes [1,2]. Diabetic retinopathy, a consequence of long-term and unregulated diabetes, poses a significant threat to both vision and overall well-being. It originates from the intricate interplay of high blood sugar levels and the delicate blood vessels that support the retina – a complex tissue at the back of the eye responsible for sending visual signals to the brain. Elevated blood sugar triggers small vessel changes that jeopardize the integrity of these retinal blood vessels [2,3]. As time passes, these vessels may start to leak or burst, leading to swelling in the retina, hemorrhages, and the eventual development of abnormal blood vessels. These irregularities not only hinder vision but also pave the way for a series of events that can result in a person losing their sight. One particularly sneaky aspect of diabetic retinopathy is its subtle progression. In its initial phases, the condition often develops without clear symptoms, leaving individuals unaware of the approaching threat to their eyes. Noticeable changes in vision may only occur when the disease has significantly progressed, at which point the damage may be irreversible [4]. This emphasizes the crucial role of routine eye screenings and thorough examinations in effectively managing and preventing diabetic retinopathy. These proactive steps enable eye specialists to identify subtle changes in the retina and take timely actions well before there is irreversible damage to vision. As we step into the realm of safeguarding eyesight through the control and prevention of diabetic retinopathy, we embark on a journey that combines medical expertise with the practice of proactive care. This journey involves exploring medical treatments that address issues within the retina, such as laser therapies and advanced anti-vascular endothelial growth factor (VEGF) treatments that hinder the growth of new blood vessels [5]. Yet, safeguarding vision goes beyond the walls of medical institutions and reaches into the realm of personal responsibility. Successful management requires a steadfast commitment to regulating blood sugar levels through a careful balance of dietary choices, physical activity, and medication. The key to preventing diabetic retinopathy involves intentional choices – a lifestyle that prioritizes overall well-being and combats the influence of high blood sugar [6,7].

1.1 Understanding diabetic retinopathy

Diabetic retinopathy, a complex and advancing eye condition, arises as a significant consequence of uncontrolled diabetes. To truly understand the importance of this condition, it is essential to explore the intricate connection between metabolic issues and visual health. At the heart of this understanding is a complicated story that involves the tiny blood vessels in the retina, compromised integrity, and the gradual decline of one’s ability to see clearly [2,8,9]. Diabetic retinopathy acts as a smaller representation within the larger narrative of vascular issues associated with diabetes. The increased levels of blood glucose, a characteristic feature of diabetes, initiate a disturbance within the layers of the retina. The fragile blood vessels in the retina, crucial for supporting its health, get entangled in the consequences of continuous high blood sugar. This process is akin to a slow breakdown of the structure that supports and maintains the visual process. As the condition progresses, it moves through distinct stages [10,11]. The first stage, known as nonproliferative diabetic retinopathy, is defined by the presence of small bulges in the blood vessels, bleeding in the retina, and the seeping of blood into retinal tissues. Although these tiny occurrences may go unnoticed initially, collectively, they create problems in the retinal landscape. As time passes, the condition can advance to proliferative diabetic retinopathy, where abnormal blood vessels begin to appear. These fragile vessels are prone to break and leak, intensifying the chaos in the retinal environment. The visual consequences of this vascular disturbance are significant, often leading to distorted or blurry vision, and in severe cases, even permanent blindness [11,12]. Understanding diabetic retinopathy goes beyond simply recognizing its anatomical intricacies. It requires delving into the ever-changing and delicate balance that dictates our ability to see. This condition highlights not only the importance of controlling metabolism but also the broader impacts of diabetes on the intricate fabric of human health. As we venture into this exploration, we reveal the significant effects of diabetic retinopathy on the intricate weaving of vision – a tapestry often overlooked until the threat of chronic disease endangers its existence [13,14].

1.2 The silent progression

Diabetic retinopathy, a subtle yet potentially severe complication of diabetes, weaves its complex story in the realm of vision. Similar to a hidden intruder, it progresses quietly and often goes unnoticed until its effect on eyesight becomes unmistakable [15]. The hidden progression emphasizes the crucial need to stay vigilant, have routine eye check-ups, and take a proactive stance to protect the precious gift of sight. Essentially, the silent advancement of diabetic retinopathy tells a story of vascular chaos. The elevated levels of blood sugar, a key characteristic of diabetes, act as the trigger for a series of intricate events within the tiny blood vessels of the retina [16,17]. Over time, these tiny blood vessels, crucial for providing nourishment to the retina, yield to the relentless impact of chronic hyperglycemia. They become fragile, leak, and occasionally give rise to abnormal growths, disrupting the finely orchestrated visual harmony conducted by the eye. The subtlety of this progression is evident in its early stages, where symptoms are conspicuously absent. As diabetic retinopathy advances quietly, vision appears unaffected, creating a false sense of security for individuals. Yet beneath this surface, a complex array of changes is unfolding. Microaneurysms, hemorrhages, and the gradual thickening of retinal layers may subtly alter the topography of the retina [18,19]. Symptoms usually become noticeable only after diabetic retinopathy has significantly advanced. Blurred or distorted vision, the emergence of dark spots, and changes in color perception may signal a more progressed stage of the disease. However, by this point, irreversible damage to visual function may have already occurred. The inherent delay between the disease’s progression and symptom manifestation highlights the crucial importance of early detection through regular eye screenings, especially for individuals with diabetes [20,21]. Regular eye check-ups serve as a metaphorical beacon, cutting through the veil of silent progression. Dilated eye exams enable ophthalmologists to delve into the depths of the eye, revealing subtle changes in the retina before they translate into noticeable vision problems. Armed with this information, healthcare professionals can customize interventions, which may include laser therapies, anti-VEGF injections, and careful blood sugar management, to halt or slow down the progression of diabetic retinopathy [21,22]. In a world where the gift of sight is frequently overlooked, the subtle advance of diabetic retinopathy serves as a powerful reminder of its vulnerability. Taking a proactive approach to eye health allows individuals to thwart this inconspicuous intruder, exposing its presence before irreversible damage occurs. With regular screenings, careful diabetes management, and timely interventions, the quiet progression of diabetic retinopathy does not have to lead to a muted future without the vibrant colors that enrich our lives [23,24].

1.3 Causes and risk factors

Diabetic retinopathy, a formidable outcome of diabetes, tells a story of intricate interactions between metabolic turmoil and ocular fragility. While the core of this condition lies in the disruption of retinal microvasculature, a multitude of elements both amplify and alleviate its consequences. Grasping the origins and factors that elevate the risk of diabetic retinopathy is pivotal for devising strategies for prevention and control [25,26,27].

1.3.1 Causes

Central to diabetic retinopathy is the pervasive impact of heightened blood sugar levels, a defining trait of diabetes. Chronic hyperglycemia sets off a sequence of events that undermine the delicate equilibrium within the retinal microenvironment. The intricate web of blood vessels that supplies the retina becomes a battleground, as prolonged exposure to elevated glucose levels weakens their walls. These compromised vessels then leak blood and fluid, distorting the retinal landscape and impairing vision. The duration of hyperglycemia emerges as a crucial driving factor, underscoring the significance of early diabetes diagnosis and effective management [28,29,30].

1.3.2 Risk factors

  1. Duration of diabetes: The length of time an individual grapples with diabetes directly shapes the risk of diabetic retinopathy. Prolonged exposure to elevated blood sugar levels heightens the chances of vascular harm within the retina [31].

  2. Blood sugar management: Suboptimal control of blood glucose escalates the vulnerability to diabetic retinopathy. Those who struggle to maintain ideal glucose levels face an increased susceptibility to the microvascular damage characteristic of this condition [32].

  3. Blood pressure: Hypertension compounds the risk of diabetic retinopathy by intensifying vascular impairment. Elevated blood pressure strains the delicate blood vessels in the retina, hastening their deterioration [33].

  4. Cholesterol levels: Elevated levels of low-density lipoprotein (LDL) cholesterol, commonly referred to as “bad” cholesterol, correlate with an augmented risk of diabetic retinopathy. High cholesterol contributes to the overall vascular damage underpinning this condition [34].

  5. Pregnancy: For women with preexisting diabetes, pregnancy can heighten the risk of diabetic retinopathy. The fluctuating hormonal environment during pregnancy can exacerbate vascular changes within the retina [35].

  6. Ethnicity: Certain ethnic groups, like African Americans, Hispanics, and Native Americans, confront a heightened predisposition to diabetic retinopathy. Genetic factors and disparities in diabetes management might contribute to this elevated risk [36].

  7. Genetic susceptibility: Family history can influence an individual’s susceptibility to diabetic retinopathy. Genetic elements may dictate a person’s inclination to develop abnormalities in retinal microvessels [37].

  8. Smoking: Smoking magnifies vascular damage and can accelerate the progression of diabetic retinopathy. The detrimental effects of smoking compound the already intricate interplay between diabetes and retinal health [38].

Comprehending the roots and risk factors exposes the complex pattern influencing the course of diabetic retinopathy. By managing modifiable risk factors through careful regulation of blood sugar, control of blood pressure, and adopting a health-conscious lifestyle, individuals can reduce their vulnerability to this potentially vision-threatening complication. In addition, increased awareness and routine eye examinations provide essential tools for early detection and intervention, emphasizing the significance of knowledge and proactive healthcare in protecting valuable vision [1,38,39,40].

2 Strategies for management

Diabetic retinopathy, an intricate and potentially vision-threatening complication of diabetes, necessitates a multidimensional and preemptive approach to its management. Navigating this elaborate landscape mandates an in-depth comprehension of the ailment, a resolute dedication to medical interventions, and a comprehensive embrace of lifestyle adjustments [41,42]. Let’s delve into the comprehensive strategies for effectively managing diabetic retinopathy:

  1. Glycemic control: Attaining and sustaining optimal blood sugar levels stand as paramount. Consistent regulation of glucose curbs the harm to retinal blood vessels, which characterizes diabetic retinopathy. Regular monitoring of blood sugar, meticulous management of insulin or medications, and mindful dietary selections constitute pivotal components. Close collaboration with healthcare experts to establish personalized glycemic targets and adapt treatment regimens is pivotal for enduring success [43].

  2. Blood pressure and cholesterol regulation: Elevated blood pressure and cholesterol exacerbate retinal impairment. Effectively managing blood pressure via medications, lifestyle adaptations, and stress alleviation bolsters vascular health. Lowering LDL cholesterol and boosting high-density lipoprotein cholesterol, often achieved through a blend of medications and dietary modifications, aids in curbing the progression of diabetic retinopathy [44].

  3. Medical interventions: Medical therapies assume a pivotal role in diabetic retinopathy management. Laser photocoagulation, a precisely aimed treatment, seals leaky blood vessels and diminishes retinal inflammation. Intravitreal injections of anti-VEGF medications hinder the growth of irregular blood vessels. Executed by skilled ophthalmologists, these interventions are tailored to the stage and severity of diabetic retinopathy [45].

  4. Regular ocular examinations: Routine eye assessments serve as the foundation of diabetic retinopathy management. Comprehensive dilated eye exams, conducted by eye care specialists, facilitate early detection of retinal modifications. The frequency of these evaluations is often contingent upon the condition’s severity and healthcare provider recommendations [8,46].

  5. Lifestyle adjustments: Adopting a health-conscious lifestyle can profoundly influence diabetic retinopathy management. A diet rich in antioxidants, whole grains, lean proteins, and healthy fats contributes to overall well-being, including retinal health. Regular physical activity enhances cardiovascular function and aids in blood sugar control. Steering clear of tobacco and moderating alcohol intake additionally safeguards the delicate retinal microvasculature [47].

  6. Adherence to medication: Diligently adhering to prescribed medications, encompassing diabetes medications and those targeting blood pressure and cholesterol, is of utmost importance. Consistent medication use sustains stable metabolic parameters, lessening the risk of retinal impairment [48].

  7. Education and empowerment: Knowledge empowers individuals to actively engage in the management of diabetic retinopathy. Comprehending the condition, its progression, and the significance of interventions fosters well-informed decision-making. Learning self-monitoring techniques, identifying symptoms, and promptly seeking medical attention empower individuals to take charge of their ocular health [49].

  8. Emotional well-being: Living with diabetic retinopathy can evoke emotional and psychological challenges. Seeking emotional support, participating in support groups, and practicing stress-reduction techniques aid individuals in coping with the emotional dimensions of managing a chronic condition [50].

  9. Collaborative healthcare: Engaging in collaborative healthcare augments diabetic retinopathy management. A multidisciplinary healthcare team, encompassing endocrinologists, ophthalmologists, nurses, dietitians, and psychologists, offers comprehensive support, addressing the diverse aspects of the condition [51].

  10. Ongoing monitoring and adaptation: Diabetic retinopathy management is an ongoing voyage. Regular follow-up appointments, continual blood sugar monitoring, and adjustments to treatment plans ensure that management approaches remain aligned with individual needs and the evolving nature of the condition [52].

In the intricate realm of managing diabetic retinopathy, a harmonious fusion of medical proficiency, lifestyle commitment, and patient empowerment holds the key. By meticulously addressing each facet of the condition, individuals can adeptly navigate the complexities of diabetic retinopathy, preserving the cherished gift of sight while enhancing overall well-being [53,54].

3 Prevention is key

Preventing the emergence of diabetic retinopathy, a potential threat to vision resulting from diabetes, requires a proactive undertaking that hinges on a thorough grasp of risk factors, vigilant self-care, and regular medical oversight. By embracing a comprehensive approach to prevention, individuals can safeguard their vision from the intricate interplay of hyperglycemia and retinal vulnerability [55,56].

  1. Diabetes management: Effective prevention of diabetic retinopathy starts with meticulous diabetes management. Swift diagnosis, adherence to prescribed medications, and consistent control of blood sugar levels form the bedrock. Regular monitoring of blood glucose empowers individuals to maintain stable levels, thereby mitigating the sustained harm that drives retinal degeneration [57,58].

  2. Blood pressure and cholesterol regulation: Sustaining healthy blood pressure and cholesterol levels contributes to diabetic retinopathy prevention. Regular blood pressure assessments, adherence to medications, and dietary adjustments collectively safeguard the integrity of retinal microvessels, ultimately lowering the risk of complications [58,59].

  3. Regular eye screenings: Regular ocular examinations, even in the absence of noticeable symptoms, stand as pivotal in early detection and prevention. Through dilated eye exams, subtle retinal changes are unveiled, enabling timely intervention before diabetic retinopathy takes hold. Early identification empowers medical professionals to employ strategies that can halt or decelerate the progression of the ailment [60].

  4. Health-conscious lifestyle: The adoption of a health-oriented lifestyle serves as a vital defense against diabetic retinopathy. A diet rich in nutrient-dense foods, balanced macronutrients, and antioxidants bolsters overall vascular health, including the delicate retinal vessels. Regular physical activity enhances cardiovascular function, aiding in blood sugar control and decreasing the likelihood of complications [61].

  5. Cessation of smoking and moderate alcohol consumption: Putting an end to smoking is crucial for diabetic retinopathy prevention. The detrimental effects of smoking amplify vascular harm, augmenting the risk of retinal complications. Limiting alcohol intake further nurtures retinal health and overall well-being [62].

  6. Consistent medical follow-up: Frequent medical check-ups provide a platform for ongoing preventive measures. A close partnership with healthcare practitioners enables adjustments to treatment plans, medication routines, and lifestyle strategies based on individual needs and evolving health dynamics [63].

  7. Genetic awareness: Grasping one’s genetic predisposition to diabetic retinopathy offers insights into individual vulnerability. Equipped with this knowledge, individuals can adopt heightened vigilance, embracing preventive measures customized to their genetic makeup [64].

  8. Diabetes education: Education equips individuals with the information needed to make informed decisions. Understanding risks, recognizing symptoms, and appreciating the importance of preventive measures foster active involvement in diabetic retinopathy prevention [65].

  9. Emotional and psychological well-being: Coping with diabetes and its potential consequences can evoke emotional hurdles. Prioritizing mental wellness through stress reduction, mindfulness techniques, and seeking support from healthcare professionals or support groups contributes to overall preventive endeavors [6].

  10. Community awareness and advocacy: Elevating awareness about diabetic retinopathy within communities and advocating for regular eye screenings and diabetes management furthers preventive efforts. Empowering others with knowledge cultivates a collective commitment to preserving vision [66].

In the realm of diabetic retinopathy prevention, knowledge translates to power, and action is paramount. By interweaving medical expertise, lifestyle choices, and individual empowerment, individuals can construct a robust defense against the inconspicuous progression of this condition. As the guardians of their own ocular health, individuals are poised to reshape the narrative, shielding their vision from diabetes’ impact and savoring the vibrant mosaic of the world through their eyes [67,68].

4 Impact on quality of life

The influence of diabetic retinopathy on an individual’s quality of life is profound and extends to various dimensions, reaching beyond mere physical implications to encompass emotional, social, and psychological facets. Diabetic retinopathy, characterized by its gradual progression and potential for causing blindness, wields the power to significantly alter one’s overall state of well-being, reshaping their daily encounters and interactions with the world [69,70].

  1. Impaired vision: The most direct and immediate consequence of diabetic retinopathy manifests in visual impairment. As the condition advances, it induces symptoms such as blurred vision, dark spots, and distortions. In severe instances, complete loss of vision becomes a stark reality [70]. This visual impairment substantially disrupts routine activities such as reading, driving, recognizing faces, and even basic mobility. Such limitations often lead to feelings of frustration, reliance on others, and a sense of helplessness [71].

  2. Emotional welfare: Diabetic retinopathy frequently triggers a cascade of emotional reactions, encompassing anxiety, depression, and a pervasive sense of isolation. The erosion of independence coupled with the fear of further visual deterioration contributes to heightened stress and emotional turmoil [72]. Individuals may grapple with a profound sense of grief over the gradual fading of their ability to perceive the world as they once did [72,73].

  3. Engagement in social life: The visual impediments stemming from diabetic retinopathy impede an individual’s capacity to partake in social activities and nurture relationships. The apprehension of being unable to fully engage in social gatherings or savor hobbies and passions may precipitate social withdrawal [74]. This retreat from social interactions can engender feelings of loneliness and potentially erode an individual’s sense of connection and belonging within their social circles [75].

  4. Professional challenges: The capacity to work and maintain a career is often essential for financial stability and a sense of purpose. Diabetic retinopathy can profoundly hinder an individual’s ability to execute their job effectively, potentially leading to job loss or a reduction in work hours. Consequently, this may trigger financial strain and a loss of one’s professional identity [74,76].

  5. Impact on caregivers: The repercussions of diabetic retinopathy reverberate beyond the individual affected. Caregivers, whether family members or friends, who assume the responsibility of supporting those with visual impairment, are not exempt from the emotional toll. The demands of caregiving may result in emotional strain, heightened stress levels, and an alteration of their own quality of life [77].

  6. Daily life challenges: Mundane daily tasks that were once taken for granted can transform into arduous endeavors or even insurmountable obstacles due to visual impairment [78]. These tasks encompass fundamental activities such as cooking, cleaning, medication management, and personal grooming. The necessity for assistance with these routine chores can erode an individual’s sense of autonomy and contribute to a diminished quality of life [79].

  7. Financial strain: The financial ramifications of diabetic retinopathy can be substantial. Expenses linked to medical treatments, assistive devices, and frequent eye examinations accumulate over time [80]. In addition, the potential loss of income due to decreased work productivity or job loss adds to the financial burden, further impacting an individual’s financial well-being [80,81].

  8. Adaptive coping mechanisms: Although the impact of diabetic retinopathy on quality of life is profound, individuals frequently develop adaptive strategies to contend with these challenges. Rehabilitation programs, assistive technologies, counseling, and participation in support groups serve as invaluable resources that foster independence, emotional well-being, and an overall enhanced quality of life [82,83].

The ramifications of diabetic retinopathy reverberate across numerous facets, affecting the physical, emotional, social, and economic dimensions of an individual’s life [84]. Acknowledging and addressing these challenges through medical interventions, emotional support, rehabilitation, and the nurturing of a supportive network can aid those affected by diabetic retinopathy in navigating its repercussions, enabling them to strive for an improved quality of life [85,86].

5 Future directions and research

Research and future directions in the field of diabetic retinopathy offer a promising pathway toward enhancing our comprehension, prevention, and management of this intricate and potentially vision-threatening ailment [87]. Continuous scientific investigations are aimed at unraveling fresh insights, pioneering interventions, and refined methodologies to optimize patient outcomes [88,89]. Several pivotal domains are set to shape the trajectory of diabetic retinopathy research in the forthcoming years:

  1. Early detection and monitoring techniques: Prioritizing the development of more precise and sensitive techniques for the early detection and monitoring of diabetic retinopathy emerges as a cornerstone of research. Cutting-edge imaging technologies, including optical coherence tomography and adaptive optics, are under scrutiny to offer high-resolution visualization of retinal structures, enabling the prompt identification of subtle changes [90,91].

  2. Biomarkers: A pivotal pursuit involves the identification of dependable biomarkers that correlate with the progression of diabetic retinopathy, potentially facilitating early diagnosis and prognosis. Researchers are delving into diverse molecular, genetic, and proteomic markers present in blood and ocular fluids, aiming to unearth potential indicators of disease onset and advancement [92].

  3. Personalized treatment approaches: The momentum behind personalized treatment strategies, tailored to individual patient attributes and disease subtypes, continues to gather strength. Precision medicine endeavors are focused on pinpointing genetic and molecular factors that influence an individual’s response to specific therapies, thereby enabling more targeted and efficacious interventions [11,93].

  4. Neuroprotection and regeneration: Beyond addressing vascular changes, a burgeoning interest lies in exploring neuroprotective and regenerative treatments for diabetic retinopathy. Research is committed to formulating interventions that bolster the viability and function of retinal neurons, addressing the underlying neurodegenerative facets of the ailment [11].

  5. Drug delivery systems: Advances in drug delivery systems are under exploration to heighten the effectiveness and durability of diabetic retinopathy treatments. Prolonged-release implants, intravitreal devices, and gene therapies are being investigated to enhance the precision of drug delivery and curtail treatment frequency [94].

  6. Artificial intelligence (AI) and machine learning (ML): The fusion of AI and ML algorithms holds immense potential in the domains of diabetic retinopathy diagnosis and risk projection. AI-driven image analysis has the potential to automate the identification of retinal irregularities, offering invaluable support to healthcare providers in making timely clinical judgments [94,95].

  7. Telemedicine and remote monitoring: The realm of telemedicine platforms and remote monitoring technologies presents an avenue to expand access to diabetic retinopathy screening and follow-up care, particularly in underserved or geographically distant regions. These platforms facilitate prompt assessment and intervention, mitigating barriers to routine eye assessments [96,97].

  8. Lifestyle interventions and behavioral science: The exploration of behavioral and lifestyle elements that influence the progression and development of diabetic retinopathy is a burgeoning avenue of research. Studies endeavor to elucidate the impact of dietary choices, physical activity, smoking cessation, and stress reduction on retinal health, guiding the formulation of comprehensive patient care plans [98].

  9. Patient education and engagement: The effectiveness of patient education and engagement strategies in preventing and managing diabetic retinopathy is paramount. Research is channeling efforts toward crafting tailored interventions that empower individuals with diabetes to actively partake in their ocular health and adhere to suggested screenings and treatments [99].

  10. Global health initiatives: Addressing the global burden of diabetic retinopathy necessitates collaborative endeavors aimed at enhancing awareness, healthcare accessibility, and the affordability of treatments. Research initiatives are directed at devising sustainable and scalable solutions to reach individuals in resource-constrained settings [100,101].

The ongoing trajectory of diabetic retinopathy research encompasses a multipronged approach, encompassing early detection, personalized therapies, technological innovations, and patient-centric care methodologies. The synergy of scientific progress, technological breakthroughs, and patient-centered strategies holds the potential to usher in a transformative era in the realms of diabetic retinopathy prevention, diagnosis, and management. In doing so, it has the power to significantly enhance the lives of countless individuals who face the risk of vision impairment [101,102].

6 Conclusion

Preserving eyesight in the presence of diabetic retinopathy necessitates a proactive approach grounded in understanding, vigilance, and strategic management. Originating from uncontrolled diabetes, this condition progressively damages retinal blood vessels, potentially leading to irreversible blindness. Effective management involves precise control of blood sugar levels, blood pressure, and cholesterol, supported by medical interventions such as laser treatments and injections. Regular ocular examinations serve as crucial means of early detection, allowing timely intervention before significant damage occurs. Prevention involves adopting a health-conscious lifestyle, staying informed about diabetes care, and promoting community awareness. By embracing a comprehensive strategy, individuals can advocate for their visual well-being, adeptly navigating the delicate balance between metabolic control and the preservation of retinal integrity. In the narrative of safeguarding sight, the roles of knowledge, commitment, and collaboration with healthcare professionals shine, paving the way to a future where the threat of diabetic retinopathy to vision is managed and restricted.

Acknowledgments

We are sincerely grateful to the authors whose unwavering review articles and invaluable contributions played a pivotal role in successfully completing this review article.

  1. Funding information: The authors state no funding involved.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Conflict of interest: The authors state no conflict of interest.

  4. Ethical approval: The conducted research is not related to either human or animal use.

  5. Data availability statement: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

[1] Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2003;26(suppl_1):s99–102.10.2337/diacare.26.2007.S99Search in Google Scholar

[2] Stitt AW, Curtis TM, Chen M, Medina RJ, McKay GJ, Jenkins A, et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retinal Eye Res. 2016;51:156–86.10.1016/j.preteyeres.2015.08.001Search in Google Scholar PubMed

[3] Fong DS, Aiello LP, Ferris III FL, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27(10):2540–53.10.2337/diacare.27.10.2540Search in Google Scholar PubMed

[4] Zhang X, Saaddine JB, Chou C-F, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649–56.10.1001/jama.2010.1111Search in Google Scholar PubMed PubMed Central

[5] Ferris FL. How effective are treatments for diabetic retinopathy? JAMA. 1993;269(10):1290–1.10.1001/jama.269.10.1290Search in Google Scholar

[6] Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136(1):122–35.10.1016/S0002-9394(03)00219-8Search in Google Scholar PubMed

[7] Tang J. Inflammation in diabetic retinopathy. Prog Retinal Eye Res. 2011;30(5):343–58.10.1016/j.preteyeres.2011.05.002Search in Google Scholar PubMed PubMed Central

[8] Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI insight. 2017;2(14):e93751.10.1172/jci.insight.93751Search in Google Scholar PubMed PubMed Central

[9] Stitt AW, Lois N, Medina RJ, Adamson P, Curtis TM. Advances in our understanding of diabetic retinopathy. Clin Sci (London, Engl : 1979). 2013;125(1):1–17.10.1042/CS20120588Search in Google Scholar PubMed

[10] Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17(4):195–206.10.1038/s41574-020-00451-4Search in Google Scholar PubMed PubMed Central

[11] Fenwick EK, Pesudovs K, Rees G, Dirani M, Kawasaki R, Wong TY, et al. The impact of diabetic retinopathy: understanding the patient’s perspective. Br J Ophthalmol. 2011;95(6):774–82.10.1136/bjo.2010.191312Search in Google Scholar PubMed

[12] Fong DS, Gottlieb J, Ferris FL, Klein R. Understanding the value of diabetic retinopathy screening. Arch Ophthalmol. 2001;119(5):758–60.10.1001/archopht.119.5.758Search in Google Scholar PubMed

[13] Barber AJ. Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss. Sci China Life Sci. 2015;58:541–9.10.1007/s11427-015-4856-xSearch in Google Scholar PubMed

[14] Powers M, Greven M, Kleinman R, Nguyen QD, Do D. Recent advances in the management and understanding of diabetic retinopathy. F1000Research. 2017;6:2063.10.12688/f1000research.12662.1Search in Google Scholar PubMed PubMed Central

[15] Mounirou BA, Adam ND, Yakoura AK, Aminou MS, Liu YT. Diabetic retinopathy: an overview of treatments. Indian J Endocrinol Metab. 2022;26(2):111–8.10.4103/ijem.ijem_480_21Search in Google Scholar PubMed PubMed Central

[16] Sabanayagam C, Banu R, Chee ML, Lee R, Wang YX, Tan G, et al. Incidence and progression of diabetic retinopathy: a systematic review. Lancet Diabetes Endocrinol. 2019;7(2):140–9.10.1016/S2213-8587(18)30128-1Search in Google Scholar PubMed

[17] Behl T, Kaur I, Kotwani A. Implication of oxidative stress in progression of diabetic retinopathy. Surv Ophthalmol. 2016;61(2):187–96.10.1016/j.survophthal.2015.06.001Search in Google Scholar PubMed

[18] Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015;64(2):631–42.10.2337/db14-0930Search in Google Scholar PubMed PubMed Central

[19] Klein R, Klein BE, Moss SE, Davis MD. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? DeMets. 1989;149(11):2427–32.10.1001/archinte.149.11.2427Search in Google Scholar

[20] Klein R, Klein BE, Moss SE, Davis MD. The wisconsin epidemiologic study of diabetic retinopathy: IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (Chicago, Ill : 1960). 1989;107(2):237–43.10.1001/archopht.1989.01070010243030Search in Google Scholar PubMed

[21] Chung J, Kim MY, Kim HS, Yoo JS, Lee YC. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refractive Surg. 2002;28(4):626–30.10.1016/S0886-3350(01)01142-7Search in Google Scholar

[22] Krepler K, Biowski R, Schrey S, Jandrasits K, Wedrich A. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefe's Archive Clin Exp Ophthalmol. 2002;240:735–8.10.1007/s00417-002-0530-7Search in Google Scholar PubMed

[23] Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology. 2014;121(12):2443–51.10.1016/j.ophtha.2014.07.019Search in Google Scholar PubMed PubMed Central

[24] Schwartzman ML, Iserovich P, Gotlinger K, Bellner L, Dunn MW, Sartore M, et al. Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy. Diabetes. 2010;59(7):1780–8.10.2337/db10-0110Search in Google Scholar PubMed PubMed Central

[25] Wat N, Wong RL, Wong IY. Associations between diabetic retinopathy and systemic risk factors. Hong Kong Med J. 2016;22(6):589–99.10.12809/hkmj164869Search in Google Scholar PubMed

[26] Scanlon PH. Improving the screening of risk factors in diabetic retinopathy. Expert Rev Endocrinol Metab. 2022;17(3):235–43.10.1080/17446651.2022.2078305Search in Google Scholar PubMed

[27] Kyari F, Tafida A, Sivasubramaniam S, Murthy GV, Peto T, Gilbert CEJBPH. Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Pub Health. 2014;14(1):1–12.10.1186/1471-2458-14-1299Search in Google Scholar PubMed PubMed Central

[28] Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Survey Ophthalmol. 2012;57(4):347–70.10.1016/j.survophthal.2012.01.004Search in Google Scholar PubMed

[29] Krishnaiah S, Das T, Nirmalan PK, Shamanna BR, Nutheti R, Rao GN, et al. Risk factors for diabetic retinopathy: Findings from the Andhra Pradesh eye disease study. Clin Ophthalmol. 2007;1(4):475–82.Search in Google Scholar

[30] Liu Y, Yang J, Tao L, Lv H, Jiang X, Zhang M, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017;7(9):e016280.10.1136/bmjopen-2017-016280Search in Google Scholar PubMed PubMed Central

[31] Zhang G, Chen H, Chen W, Zhang M. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–5.10.1136/bjophthalmol-2017-310316Search in Google Scholar PubMed PubMed Central

[32] Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study. Medicine. 2020;99(9):e19236.10.1097/MD.0000000000019236Search in Google Scholar PubMed PubMed Central

[33] Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869–75.10.1016/j.ophtha.2008.05.014Search in Google Scholar PubMed

[34] Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care. 2012;35(3):556–64.10.2337/dc11-1909Search in Google Scholar PubMed PubMed Central

[35] Liu L, Wu J, Yue S, Geng J, Lian J, Teng W, et al. health, Incidence density and risk factors of diabetic retinopathy within type 2 diabetes: a five-year cohort study in China (Report 1). Int J Env Res public health. 2015;12(7):7899–909.10.3390/ijerph120707899Search in Google Scholar PubMed PubMed Central

[36] Pedro R-A, Ramon S-A, Marc B-B, Juan F-B, Isabel M-M. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol. 2010;17(4):251–65.10.3109/09286586.2010.498661Search in Google Scholar PubMed

[37] Ghaem H, Daneshi N, Riahi S, Dianatinasab M. The prevalence and risk factors for diabetic retinopathy in Shiraz, Southern Iran. Diabetes Metab J. 2018;42(6):538–43.10.4093/dmj.2018.0047Search in Google Scholar PubMed PubMed Central

[38] Hou Y, Cai Y, Jia Z, Shi S. Risk factors and prevalence of diabetic retinopathy: A protocol for meta-analysis. Medicine. 2020;99(42):22695.10.1097/MD.0000000000022695Search in Google Scholar PubMed PubMed Central

[39] Janghorbani M, Amini M, Ghanbari H, Safaiee H. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiol. 2003;10(2):81–95.10.1076/opep.10.2.81.13893Search in Google Scholar PubMed

[40] Magliah SF, Bardisi W, Al Attah M. The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals. J Family Med Prim care. 2018;7(5):975–81.10.4103/jfmpc.jfmpc_85_18Search in Google Scholar PubMed PubMed Central

[41] Frank RN. Evolving strategies in the management of diabetic retinopathy. Middle East Afr J Ophthalmol. 2013;20(4):273.10.4103/0974-9233.119993Search in Google Scholar PubMed PubMed Central

[42] Bandello F, Zarbin MA, Lattanzio R, Zucchiatti I. Clinical strategies in the management of diabetic retinopathy. Springer-Verlag Berlin An; 2016.10.1159/isbn.978-3-318-06042-3Search in Google Scholar

[43] Beaser RS, Turell WA, Howson A. Strategies to improve prevention and management in diabetic retinopathy: qualitative insights from a mixed-methods study. Diabetes Spectr. 2018;31(1):65–74.10.2337/ds16-0043Search in Google Scholar PubMed PubMed Central

[44] Selvaraj K, Gowthamarajan K, Karri VVSR, Barauah UK, Ravisankar V. Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy. J Drug Target. 2017;25(5):386–405.10.1080/1061186X.2017.1280809Search in Google Scholar PubMed

[45] Wong TY, Sabanayagam C. The war on diabetic retinopathy: where are we now? Asia-Pacific J Ophthalmol. 2019;8(6):448.10.1097/APO.0000000000000267Search in Google Scholar PubMed PubMed Central

[46] Singh R, Ramasamy K, Abraham C, Gupta V. Gupta Diabetic retinopathy: an update. Indian J Ophthalmol. 2008;56(3):179–88.10.4103/0301-4738.40355Search in Google Scholar

[47] Sabanayagam C, Yip W, Ting DS, Tan G, Wong TY. Ten emerging trends in the epidemiology of diabetic retinopathy. Ophthalmic Epidemiol. 2016;23(4):209–22.10.1080/09286586.2016.1193618Search in Google Scholar PubMed

[48] Al-Shabrawey M, Zhang W, McDonald D. Diabetic retinopathy: mechanism, diagnosis, prevention, and treatment. BioMed Res Int. 2015 Mar 19;2015:1–2.10.1155/2015/854593Search in Google Scholar PubMed PubMed Central

[49] Safi SZ, Qvist R, Kumar S, Batumalaie K, Ismail IS. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int. 2014;2014.10.1155/2014/801269Search in Google Scholar PubMed PubMed Central

[50] Dulull N, Kwa F, Osman N, Rai U, Shaikh B, Thrimawithana TR. Recent advances in the management of diabetic retinopathy. Drug Discovery Today. 2019;24(8):1499–509.10.1016/j.drudis.2019.03.028Search in Google Scholar PubMed

[51] Dodson PM. Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality? Eye. 2009;23(5):997–1003.10.1038/eye.2008.428Search in Google Scholar PubMed

[52] Jusufbegovic D, Mugavin MO, Schaal S. Evolution of controlling diabetic retinopathy: changing trends in the management of diabetic macular edema at a single institution over the past decade. Retina. 2015;35(5):929–34.10.1097/IAE.0000000000000438Search in Google Scholar PubMed

[53] Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region. Middle East Afr J Ophthalmol. 2012;19(2):178.10.4103/0974-9233.95245Search in Google Scholar PubMed PubMed Central

[54] Maqbool M, Gani I, Dar MA. Development, Anti-diabetic effects of some medicinal plants in experimental animals: a review. Asian J Pharm Res Dev. 2019;7(1):66–9.10.22270/ajprd.v7i1.469Search in Google Scholar

[55] Einarsdóttir AB, Stefánsson E. Prevention of diabetic retinopathy. Lancet. 2009;373(9672):1316–8.10.1016/S0140-6736(09)60750-9Search in Google Scholar PubMed

[56] Aldebasi YH, Aly SM, Rahmani A. Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. Int J Physiol Pathophysiol Pharmacol. 2013;5(4):194–202.Search in Google Scholar

[57] Frank RN. On the pathogenesis of diabetic retinopathy: a 1990 update. Ophthalmology. 1991;98(5):586–93.10.1016/S0161-6420(91)32253-XSearch in Google Scholar

[58] Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmologica Scandinavica. 2000;78(4):374–85.10.1034/j.1600-0420.2000.078004374.xSearch in Google Scholar PubMed

[59] Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44(4):260–77.10.1111/ceo.12696Search in Google Scholar PubMed

[60] Maqbool M, Zehravi M, Maqbool R, Ara I. An overview about treatment of gestational diabetes mellitus: A short communication. CELLMED. 2021;11(3):12–21.Search in Google Scholar

[61] Dodson PM. Diabetic retinopathy: treatment and prevention. Diabetes Vasc Dis Res. 2007;4(3_suppl):S9–S11.10.3132/dvdr.2007.051Search in Google Scholar PubMed

[62] Frank RN. Diabetic retinopathy and systemic factors. Middle East Afr J Ophthalmol. 2015;22(2):151.10.4103/0974-9233.154388Search in Google Scholar PubMed PubMed Central

[63] Stitt AW. AGEs and diabetic retinopathy. Investig Ophthalmol Vis Sci. 2010;51(10):4867–74.10.1167/iovs.10-5881Search in Google Scholar PubMed

[64] Shah CA. Diabetic retinopathy: A comprehensive review. Indian J Med Sci. 2008;62(12):500–19.10.4103/0019-5359.48562Search in Google Scholar

[65] Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care. 2003;26(9):2653–64.10.2337/diacare.26.9.2653Search in Google Scholar PubMed

[66] Bryl A, Mrugacz M, Falkowski M, Zorena KJN. The effect of diet and lifestyle on the course of diabetic retinopathy – A review of the literature. Nutrients. 2022;14(6):1252.10.3390/nu14061252Search in Google Scholar PubMed PubMed Central

[67] Porta M, Bandello FJD. Diabetic retinopathyA clinical update. Diabetologia. 2002;45:1617–34.10.1007/s00125-002-0990-7Search in Google Scholar PubMed

[68] Behl T, Kotwani A. Pharmacology, Chinese herbal drugs for the treatment of diabetic retinopathy. J Pharm Pharmacol. 2017;69(3):223–35.10.1111/jphp.12683Search in Google Scholar PubMed

[69] Sharma S, Oliver-Fernandez A, Liu W, Buchholz P. The impact of diabetic retinopathy on health-related quality of life. Curr OpOphthalmol. 2005;16(3):155–9.10.1097/01.icu.0000161227.21797.3dSearch in Google Scholar PubMed

[70] Davidov E, Breitscheidel L, Clouth J, Reips M. Diabetic retinopathy and health-related quality of life. Graefe’s Archive Clin Exp Ophthalmol. 2009;247:267–72.10.1007/s00417-008-0960-ySearch in Google Scholar PubMed

[71] Fenwick EK, Pesudovs K, Khadka J, Dirani M, Rees G, Wong TY, et al. The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project. Qual Life Res. 2012;21:1771–82.10.1007/s11136-012-0110-1Search in Google Scholar PubMed

[72] Woodcock A, Bradley C, Plowright R, Kennedy-Martin T, Hirsch A. The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ Counseling. 2004;53(3):365–83.10.1016/j.pec.2003.10.007Search in Google Scholar PubMed

[73] Deswal J, Narang S, Gupta N, Jinagal J. To study the impact of diabetic retinopathy on quality of life in Indian diabetic patients. Indian J Ophthalmol. 2020;68(5):848–53.10.4103/ijo.IJO_1553_19Search in Google Scholar PubMed PubMed Central

[74] Pan C-W, Wang S, Wang P, Xu C-L. Diabetic retinopathy and health-related quality of life among Chinese with known type 2 diabetes mellitus. Qual Life Res. 2018;27:2087–93.10.1007/s11136-018-1876-6Search in Google Scholar PubMed

[75] Hirai FE, Tielsch JM, Klein BE, Klein R. Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 2011;118(2):353–8.10.1016/j.ophtha.2010.06.022Search in Google Scholar PubMed PubMed Central

[76] Kobrin Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14(4):179–83.10.1080/09286580701396720Search in Google Scholar PubMed

[77] Zhu B, Ma Y, Lin S, Zou H. Vision-related quality of life and visual outcomes from cataract surgery in patients with vision-threatening diabetic retinopathy: a prospective observational study. Health Qual Life Outcomes. 2017;15(1):1–7.10.1186/s12955-017-0751-4Search in Google Scholar PubMed PubMed Central

[78] Singh RP, Elman MJ, Singh SK, Fung AE. Complications, Advances in the treatment of diabetic retinopathy. J Diabetes Complications. 2019;33(12):107417.10.1016/j.jdiacomp.2019.107417Search in Google Scholar PubMed

[79] Mahobia A, Sahoo SR, Maiti N, Sathyanarayanan R, Aravinth R, Pandraveti RR, et al. Diabetic retinopathy and its effect on quality of life: An original research. J Pharm Bioallied Sci. 2021;13(Suppl 2):S1365.10.4103/jpbs.jpbs_199_21Search in Google Scholar PubMed PubMed Central

[80] Brown MM, Brown GC, Sharma S. Utility values and diabetic retinopathy. Utility Values Diabet Retinopathy. 1999;128(3):324–30.10.1016/S0002-9394(99)00146-4Search in Google Scholar

[81] Mukamel BD, Bresnick HG, Wang Q, Dickey FC. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol. 1999;6(1):61–72.10.1076/opep.6.1.61.1563Search in Google Scholar PubMed

[82] Striglia E, Caccioppo A, Castellino N, Reibaldi M. Emerging drugs for the treatment of diabetic retinopathy. Expert Opin Emerg Drugs. 2020;25(3):261–71.10.1080/14728214.2020.1801631Search in Google Scholar PubMed

[83] Hariprasad SM, Mieler W, Grassi M, Green J, Jager R. Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol. 2008;92(1):89–92.10.1136/bjo.2007.122416Search in Google Scholar PubMed

[84] Zhang L, Chen B, Tang L. Metabolic memory: mechanisms and implications for diabetic retinopathy. Diabetes Res Clin Pract. 2012;96(3):286–93.10.1016/j.diabres.2011.12.006Search in Google Scholar PubMed

[85] Maberley D, Walker H, Koushik A, Cruess A. Screening for diabetic retinopathy in James Bay. Ontario: a cost-effectiveness analysis. CMAJ. 2003;168(2):160–4.Search in Google Scholar

[86] Lloyd A, Nafees B, Gavriel S, Rousculp M, Boye K, Ahmad AJDM. Health utility values associated with diabetic retinopathy. Diabet Med. 2008;25(5):618–24.10.1111/j.1464-5491.2008.02430.xSearch in Google Scholar PubMed

[87] Nadeem MW, Goh HG, Hussain M, Liew S-Y, Andonovic I, Khan MA. Deep learning for diabetic retinopathy analysis: A review, research challenges, and future directions. Sensors. 2022;22(18):6780.10.3390/s22186780Search in Google Scholar PubMed PubMed Central

[88] Das T, Raman R, Ramasamy K, Rani PK. Telemedicine in diabetic retinopathy: current status and future directions. Middle East Afr J Ophthalmol. 2015;22(2):174–8.10.4103/0974-9233.154391Search in Google Scholar PubMed PubMed Central

[89] Varma R. Diabetic retinopathy: challenges and future directions. Am J Ophthalmol. 2006;141(3):539–41.10.1016/j.ajo.2005.11.038Search in Google Scholar PubMed

[90] Shah AR, Gardner TW. Diabetic retinopathy: research to clinical practice. Clin Diabetes Endocrinol. 2017;3(1):1–7.10.1186/s40842-017-0047-ySearch in Google Scholar PubMed PubMed Central

[91] Fioretto P, Dodson PM, Ziegler D, Rosenson RS. Residual microvascular risk in diabetes: unmet needs and future directions. Nat Rev Endocrinol. 2010;6(1):19–25.10.1038/nrendo.2009.213Search in Google Scholar PubMed

[92] Bellemo V, Lim G, Rim TH, Tan G, Cheung CY, Sadda S, et al. Artificial intelligence screening for diabetic retinopathy: the real-world emerging application. Curr Diabetes Rep. 2019;19:1–12.10.1007/s11892-019-1189-3Search in Google Scholar PubMed

[93] Barot M, Gokulgandhi MR, Patel S. Microvascular complications and diabetic retinopathy: recent advances and future implications. Future Medicinal Chem. 2013;5(3):301–14.10.4155/fmc.12.206Search in Google Scholar PubMed PubMed Central

[94] Sherris D. Ocular drug development-future directions. Angiogenesis. 2007;10:71–6.10.1007/s10456-007-9068-ySearch in Google Scholar PubMed

[95] Bilal A, Sun G. Survey on recent developments in automatic detection of diabetic retinopathy. J Francais D’ophtalmologie. 2021;44(3):420–40.10.1016/j.jfo.2020.08.009Search in Google Scholar PubMed

[96] Cole ED, Novais EA, Louzada RN, Waheed NK. Contemporary retinal imaging techniques in diabetic retinopathy: a review. Clin Exp Ophthalmol. 2016;44(4):289–99.10.1111/ceo.12711Search in Google Scholar PubMed

[97] Sivaprasad S, Sen S, Cunha-Vaz J. Perspectives of diabetic retinopathy – challenges and opportunities. Eye. 2022;1–9.10.1038/s41433-022-02335-5Search in Google Scholar PubMed PubMed Central

[98] Nagpal D, Panda S, Malarvel M, Pattanaik PA. Sciences, A review of diabetic retinopathy: Datasets, approaches, evaluation metrics and future trends. J King Saud UnivComput Inf Sci. 2022;34(9):7138–52.10.1016/j.jksuci.2021.06.006Search in Google Scholar

[99] Das D, Biswas SK, Bandyopadhyay S. A critical review on diagnosis of diabetic retinopathy using machine learning and deep learning. Applications. 2022;81(18):25613–55.10.1007/s11042-022-12642-4Search in Google Scholar PubMed PubMed Central

[100] Zaki WMDW, Zulkifley MA, Hussain A, Halim WHW, Mustafa NBA, Ting LS. Control, Diabetic retinopathy assessment: Towards an automated system. Biomed Signal Process Control. 2016;24:72–82.10.1016/j.bspc.2015.09.011Search in Google Scholar

[101] Lim WX, Chen Z, Ahmed A. Engineering, Computing, The adoption of deep learning interpretability techniques on diabetic retinopathy analysis: a review. Med Biol Eng Comput. 2022;60(3):633–42.10.1007/s11517-021-02487-8Search in Google Scholar PubMed PubMed Central

[102] Li S, Zhao R, Zou H. Artificial intelligence for diabetic retinopathy. Chin Med J. 2022;135(3):253–60.10.1097/CM9.0000000000001816Search in Google Scholar PubMed PubMed Central

Received: 2023-08-04
Revised: 2023-11-03
Accepted: 2023-12-03
Published Online: 2023-12-31

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Social factors related to depression during COVID-19
  3. Prevalence of diaper need and diaper dermatitis and associated risk factors among children aged 1–24 months in a referral hospital in Ghana: A cross-sectional study
  4. A gravity model approach to understand the spread of pandemics: Evidence from the COVID-19 outbreak
  5. Raising security of first responders with C-ITS?
  6. Recomposition of work and attitudes of family assistants within Covid-19 in Poland: A pilot study
  7. Allelic variants of CYP2B6 gene expression and its implication on the pathogenesis of malaria among a cohort of outpatients in North-Central Nigeria
  8. Impact of medically supervised fasting on the vitamin D, glycemic control, quality of life and need for medication among type 2 diabetes mellitus: Protocol for a randomized control trial (FAVIT Trial)
  9. A Tumblr thematic analysis of perinatal health: Where users go to seek support
  10. Assessing the significance of socioeconomic and demographic factors on COVID-19 cases in Turkey along with the development levels of provinces
  11. Economic burden and health-related quality of life in patients with neurofibromatosis type 1 in Greece
  12. Review Articles
  13. The current status of diversity among physician assistants in surgery: A systematic review
  14. Planting a path to kidney health: The vegetarian diet and diabetic nephropathy
  15. Short Communications
  16. World Heart Day: Clinical case to raise awareness on cardiovascular disease in women
  17. Preserving sight: Managing and preventing diabetic retinopathy
  18. The rise of anti-vaccination legislation in two Midwestern US states: Implications for politics, policy, and society
  19. Letter to the Editor
  20. Tranexamic acid and pre-hospital trauma setting: Is everything clear by now?
  21. Pneumocephalus was commonly evident and pneumorrhachis was very commonly evident among our peri-anesthesia patients whose peri-partum neurological symptoms had warranted radiological investigations
  22. Ventilator-associated pneumonia: Epidemiological changes or disregarded bundles?
  23. Special Issue on Public Health Resilience - Part I
  24. Editorial: Special issue on public health resilience
  25. Message framing, partisanship, and popular support for COVID-19 vaccine mandate for all adults: Evidence from a preregistered survey experiment
https://doi.org/10.1515/ohe-2023-0019
Keywords for this article
diabetic retinopathy; vision loss; blood sugar; education
Creative Commons
BY 4.0

Articles in the same Issue

  1. Research Articles
  2. Social factors related to depression during COVID-19
  3. Prevalence of diaper need and diaper dermatitis and associated risk factors among children aged 1–24 months in a referral hospital in Ghana: A cross-sectional study
  4. A gravity model approach to understand the spread of pandemics: Evidence from the COVID-19 outbreak
  5. Raising security of first responders with C-ITS?
  6. Recomposition of work and attitudes of family assistants within Covid-19 in Poland: A pilot study
  7. Allelic variants of CYP2B6 gene expression and its implication on the pathogenesis of malaria among a cohort of outpatients in North-Central Nigeria
  8. Impact of medically supervised fasting on the vitamin D, glycemic control, quality of life and need for medication among type 2 diabetes mellitus: Protocol for a randomized control trial (FAVIT Trial)
  9. A Tumblr thematic analysis of perinatal health: Where users go to seek support
  10. Assessing the significance of socioeconomic and demographic factors on COVID-19 cases in Turkey along with the development levels of provinces
  11. Economic burden and health-related quality of life in patients with neurofibromatosis type 1 in Greece
  12. Review Articles
  13. The current status of diversity among physician assistants in surgery: A systematic review
  14. Planting a path to kidney health: The vegetarian diet and diabetic nephropathy
  15. Short Communications
  16. World Heart Day: Clinical case to raise awareness on cardiovascular disease in women
  17. Preserving sight: Managing and preventing diabetic retinopathy
  18. The rise of anti-vaccination legislation in two Midwestern US states: Implications for politics, policy, and society
  19. Letter to the Editor
  20. Tranexamic acid and pre-hospital trauma setting: Is everything clear by now?
  21. Pneumocephalus was commonly evident and pneumorrhachis was very commonly evident among our peri-anesthesia patients whose peri-partum neurological symptoms had warranted radiological investigations
  22. Ventilator-associated pneumonia: Epidemiological changes or disregarded bundles?
  23. Special Issue on Public Health Resilience - Part I
  24. Editorial: Special issue on public health resilience
  25. Message framing, partisanship, and popular support for COVID-19 vaccine mandate for all adults: Evidence from a preregistered survey experiment
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 2.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ohe-2023-0019/html?lang=en&srsltid=AfmBOorNLVwnae08U2W8-bUEEjoov1oRtgf0fgUYi6BUNKIUHKcBFkh5
Scroll to top button